Bio-Rad Labs (BIO) Misses Q1 EPS by 46c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $377.33 +0.24%
EPS Growth %: -1.3%
Financial Fact:
Interest expense: 5.63M
Today's EPS Names:
ALZN, ASPU, OCCI, More
EPS Growth %: -1.3%
Financial Fact:
Interest expense: 5.63M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $3.34, $0.46 worse than the analyst estimate of $3.80. Revenue for the quarter came in at $677 million versus the consensus estimate of $696.08 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Rubico to shift from semi-annual to quarterly financial reporting
- Ledyard Financial Group adds two directors, three retire
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
